• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC NEUROMODULATION VERCISE CARTESIA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS Back to Search Results
Model Number DB-2202-30
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Dysphagia/ Odynophagia (1815); Muscle Weakness (1967); Visual Disturbances (2140); Speech Disorder (4415)
Event Date 06/15/2021
Event Type  Injury  
Event Description
It was reported that the patient suffered a stroke, which was life-threatening, and was treated with medication.The physician assessed the event as recovering/resolving and possibly related to procedure and hardware, but not related to stimulation.
 
Event Description
It was reported that the patient suffered a stroke, which was life-threatening.The patient was treated with medication.The physician assessed as recovering/resolving and possibly related to procedure and hardware, but not related to stimulation.Additional information was received that the patient developed symptoms of right sided hemiparesis, homonymous hemianopia, and dysarthria.A head computed tomography scan (ct) showed evidence of ischemic stroke in the region of the left basal ganglia in proximity to the left lead implant.The patient was unable to swallow and therefore a nasogastric tube was placed to facilitate feeding and administration of parkinsons disease medications.The physician assessed the event as having a possible relationship to the procedure, but not related to hardware and stimulation.The event is recovering/resolving.
 
Manufacturer Narrative
Field a2 date of birth: 1958; exact date of birth is unknown.
 
Event Description
It was reported that the patient suffered a stroke, which was life-threatening.The patient was treated with medication.The physician assessed as recovering/resolving and possibly related to procedure and hardware, but not related to stimulation.Additional information was received that the patient developed symptoms of right sided hemiparesis, homonymous hemianopia, and dysarthria.A head computed tomography scan (ct) showed evidence of ischemic stroke in the region of the left basal ganglia in proximity to the left lead implant.The patient was unable to swallow and therefore a nasogastric tube was placed to facilitate feeding and administration of parkinsons disease medications.The physician assessed the event as having a possible relationship to the procedure, but not related to hardware and stimulation.The event is recovering/resolving.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERCISE CARTESIA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN SYMPTOMS
Manufacturer (Section D)
BOSTON SCIENTIFIC NEUROMODULATION
25155 rye canyon loop
valencia CA 91355
MDR Report Key12298503
MDR Text Key265763117
Report Number3006630150-2021-04338
Device Sequence Number1
Product Code NHL
UDI-Device Identifier08714729905271
UDI-Public08714729905271
Combination Product (y/n)N
PMA/PMN Number
P150031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 10/05/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date04/25/2023
Device Model NumberDB-2202-30
Device Catalogue NumberDB-2202-30
Device Lot Number7074234
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/16/2021
Initial Date FDA Received08/09/2021
Supplement Dates Manufacturer Received08/12/2021
09/09/2021
Supplement Dates FDA Received09/09/2021
10/05/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
-
-